CRGX Live signals | Maximize Profits with Getagraph.com

BUY 121290 min ago

@ $21.56

Issued: 14 Feb 2024 @ 14:23

Return: -5.45%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: -1.98 %

Live Chart Being Loaded With Signals

Commentary (8 May 2024 @ 16:00):

Stats
Today's Volume	139 659
Average Volume	312 060
Market Cap	802.33M
EPS	$0 ( 2024-03-27 )
Next earnings date	( $-1.050 ) 2024-06-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0380 (0.19%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-12	Rtw Investments, Lp	Sell	1 842 499	Common stock, par value $0.001 per share ("Common Stock")
2023-11-14	Rtw Investments, Lp	Buy	0	Common stock, par value $0.001 per share
2023-11-14	Perceptive Advisors Llc	Buy	333 333	Common Stock
2023-11-14	Perceptive Advisors Llc	Buy	2 579 502	Common Stock
2023-11-14	Perceptive Advisors Llc	Buy	333 333	Common Stock

INSIDER POWER
-17.48
Last 10 transactions
Buy: 3 296 168 \| Sell: 4 503 291

Volume Correlation

Long: 0.35 (neutral)

Short: -0.68 (moderate negative)

Signal:(58.655) Neutral

CARGO Therapeutics, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CARGO Therapeutics, Inc. Correlation - Currency/Commodity

-0.41
( neutral )

0.32
( neutral )

0.00
( neutral )

-0.10
( neutral )

-0.73
( moderate negative )

0.14
( neutral )

CARGO Therapeutics, Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

CARGO Therapeutics, Inc.

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.